TYSONBIO MD100 BLOOD GLUCSE MONITORING ,TYSONBIO MD100 PRO BLOOD GLUCISE MONITORING SYSTEM— 510(k) K112916

Substantially Equivalent

Tyson Bioresearch, Inc.

FDA 510(k) clearance K112916 for TYSONBIO MD100 BLOOD GLUCSE MONITORING ,TYSONBIO MD100 PRO BLOOD GLUCISE MONITORING SYSTEM, Substantially Equivalent on 2012-08-21. Applicant: Tyson Bioresearch, Inc.. Device class: 2.

Clearance details

Applicant
Tyson Bioresearch, Inc.
Product code
Code NBW
Device class
Class 2
Regulation
21 CFR 862.1345
Advisory panel
Clinical Chemistry
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
Chu-Nan, Miao-Li County, TW
Download summary PDFView on FDA.gov ↗

Recent devices under product code NBW

view all

More clearances from Tyson Bioresearch, Inc.

view all

Adverse events under product code NBW

product code NBW
Death
18
Injury
4,740
Malfunction
42,679
Other
6
Total
47,443

Source: openFDA MAUDE database, through . Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.